Author

Isabelle Searcy

Institution: Boston Scientific (United States)

Observed institution: Boston Scientific (United States)

ORCID: 0009-0003-5573-5960

Observed ORCID: 0009-0003-5573-5960

OpenAlex ID: A5117069069

Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study

2022 · Liewei Wang, Steven E. Scherer, et al. · Genetics in Medicine · 76

Efficacy of Water Vapor Thermal Therapy by Prostate Volume in Large (>80 cc) and Average (≤80 cc) Cohorts—A Systematic Review and Meta-analysis

2025 · Ahmer Farooq, Phillip Westbrook, et al. · Urology · 2

Water Vapor Thermal Therapy with Rezūm Versus Combination Pharmacotherapy for Male Lower Urinary Tract Symptoms due to Benign Prostatic Obstruction: 1-Yr Results From a Prospective, Multicenter, Pragmatic Randomized Controlled Trial (VAPEUR-RCT)

2026 · Sébastien Vincendeau, Evanguelos Xylinas, et al. · European Urology Focus

A systematic review of associations—exploring whether prostate size is related to sexual function outcomes following water vapor thermal therapy

2026 · Philip Westbrook, Ahmer Farooq, et al. · Sexual Medicine Reviews

Ip18-33 Impact of Rezūm Treatment on Sexual Function in Large and Average Prostate Volume – a Systematic Review

2025 · Philip Westbrook, Ahmer Farooq, et al. · The Journal of Urology

Works count: 5

Citation count: 78

H-index: 2

I10-index: 1